Get the Play-by-Play: How BI is Using Predictive Analytics to Tackle Non-Adherence
In this Xtalks webinar, “Leveraging Predictive Dosing to Reduce Clinical Trial Risk,” Dooti Roy, PhD, from Boehringer Ingelheim and Ken Getz from the Tufts Center for the Study of Drug Development join Rich Christie, MD, PhD, from AiCure, to discuss patient dosing patterns and how to apply predictive analytics to improve the effectiveness of clinical trials.
- Rich Christie MD PhD, Chief Development Officer at AiCure
- Ken Getz MBA, Director & Professor at Tufts Center for the Study of Drug Development, Tufts University School of Medicine
- Dooti Roy PhD, Principal Methodology Statistician at Boehringer Ingelheim
- Marlen Rattiner, VP, Product Management at AiCure (moderator)